Both Tirzepatide and Mounjaro represent new methods to addressing type 2 diabetes, and increasingly, obesity. Semaglutide is a twin agonist that works on multiple receptors involved in metabolism: GLP-1 and GIP. It, https://things-to-know-about-tir947806.nytechwiki.com/user